ALK and T-cell non-Hodgkin lymphoma: Additionally, our data lend further support to the notion that ALK-fusion proteins confer high oncogenic potential to transformed cells of different origin independently of the fusion partner and induce both B- and T-cell lymphomas in transgenic mice [3], [16].